- Supported exchanges /
- PINK /
- ETXPF.PINK
e-therapeutics plc (ETXPF PINK) stock market data APIs
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. The company offers HepNet, a hepatocyte-focused computational platform that enables identification of novel gene targets, improves drug design, and increases automation; and GalOmic, RNA interference (RNAi) platform that generates potent and safe GalNAc-siRNA therapeutics to selectively silence novel disease-associated genes in hepatocytes. Its preclinical products are ETX-312 to treat metabolic dysfunction-associated steatohepatitis; and ETX-407 for the treatment of dry age-related macular degeneration. The company also develops ETX-148 for haemophilia; ETX-291 to treat cardiometabolic disease, ETX-258 for heart failure; and ETX-394 to treat metabolic dysfunction-associated steatohepatitis. e-therapeutics plc incorporated in 2001 and is based in London, the United Kingdom.
e-therapeutics plc Financial Data Overview
0.13 | |
0.13 | |
- | |
0.13 | |
0.13 | |
0.13-0.2195 | |
75 964 K | |
584 M | |
318 K | |
0.474 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
e-therapeutics plc Fundamental Data is available in our Financial Data APIs
- Net Revenue 318 K
- EBITDA -13 723 000
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get e-therapeutics plc Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get e-therapeutics plc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: